Homebiotech

biotech

biotech

Base to Base biotech podcast 79: Fragile X syndrome and Parkinson’s disease

Jim Cornall - October 9, 2026

biotech

Novel cancer therapy blocks communication between cancer cells and cancer-associated fibroblasts

Jim Cornall - October 8, 2026

biotech

Retinitis pigmentosa cell therapy drug cleared for clinical trials in US and China

Jim Cornall - October 8, 2026

biotech

How cells fight back after bacterial toxins break through

Jim Cornall - October 8, 2026

biotech

LinkGevity awarded deeptech EU grant

Jim Cornall - September 27, 2024

AI

Healthy AI: sustainable artificial intelligence for healthcare

Jim Cornall - August 7, 2024

biotech

PK MED receives €1.5m deeptech financing to boost bone marrow transplants

Jim Cornall - July 31, 2024

biotech

European Inventor Award 2024 finalists revealed

Jim Cornall - May 29, 2024

biotech

Imec and Sarcura introduce scalable on-chip detection of human white blood cells

Jim Cornall - May 20, 2024

biotech

New ultrasound technology could transform respiratory disease diagnosis

Jim Cornall - March 28, 2024

biotech

SPT supports UKHSA genomics surveillance project to strengthen global health security

Jim Cornall - February 23, 2024

biotech

New nanosensors make diagnostic procedures more sensitive

Jim Cornall - February 15, 2024

1...102103104 Page 103 of 104

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 79: Fragile X syndrome and Parkinson’s disease

Jim Cornall - October 9, 2026 0

This week, we chat with Simon Mølgaard, co-founder and chief executive officer of Teitur Trophics about results from its Parkinson’s disease trial, and have...

Novel cancer therapy blocks communication between cancer cells and cancer-associated fibroblasts

biotech Jim Cornall - October 8, 2026 0

Retinitis pigmentosa cell therapy drug cleared for clinical trials in US and China

biotech Jim Cornall - October 8, 2026 0

How cells fight back after bacterial toxins break through

biotech Jim Cornall - October 8, 2026 0

New approach to treating chronic wounds

biotech Jim Cornall - October 7, 2026 0